Source: Medthority

Medtronic: Medtronic's Affera Technologies Show Promise for Atrial Fibrillation

Medtronic's Affera pulsed field ablation technologies, including Sphere-360 and Sphere-9 catheters, demonstrate impressive safety and efficacy in treating atrial fibrillation, as presented at the Heart Rhythm Society 2025 Annual Meeting.

Read full article »
Annual Revenue
$10-50B
Employees
50-100K
Geoffrey S. Martha's photo - Chairman & CEO of Medtronic

Chairman & CEO

Geoffrey S. Martha

CEO Approval Rating

70/100

Read more